466 related articles for article (PubMed ID: 35235159)
1. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms.
Jafari A; Danesh Pouya F; Niknam Z; Abdollahpour-Alitappeh M; Rezaei-Tavirani M; Rasmi Y
Mol Biol Rep; 2022 Jun; 49(6):4943-4957. PubMed ID: 35235159
[TBL] [Abstract][Full Text] [Related]
2. Advances in gene-based vaccine platforms to address the COVID-19 pandemic.
Pushparajah D; Jimenez S; Wong S; Alattas H; Nafissi N; Slavcev RA
Adv Drug Deliv Rev; 2021 Mar; 170():113-141. PubMed ID: 33422546
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
[TBL] [Abstract][Full Text] [Related]
4. A perspective on SARS-CoV-2 virus-like particles vaccines.
Gao X; Xia Y; Liu X; Xu Y; Lu P; Dong Z; Liu J; Liang G
Int Immunopharmacol; 2023 Feb; 115():109650. PubMed ID: 36649673
[TBL] [Abstract][Full Text] [Related]
5. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects.
Zhang Z; Shen Q; Chang H
Front Immunol; 2022; 13():843928. PubMed ID: 35572592
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2: vaccines in the pandemic era.
Li DD; Li QH
Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
[TBL] [Abstract][Full Text] [Related]
7. Super-rapid race for saving lives by developing COVID-19 vaccines.
Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A
J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 vaccine candidates in rapid development.
Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
[TBL] [Abstract][Full Text] [Related]
9. A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.
Abdolmaleki G; Taheri MA; Paridehpour S; Mohammadi NM; Tabatabaei YA; Mousavi T; Amin M
Daru; 2022 Dec; 30(2):379-406. PubMed ID: 36050585
[TBL] [Abstract][Full Text] [Related]
10. A review of the safety and efficacy of current COVID-19 vaccines.
Huang Z; Su Y; Zhang T; Xia N
Front Med; 2022 Feb; 16(1):39-55. PubMed ID: 35122210
[TBL] [Abstract][Full Text] [Related]
11. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
[TBL] [Abstract][Full Text] [Related]
12. A survey of mechanisms underlying current and potential COVID-19 vaccines.
Hebel C; Thomsen AR
APMIS; 2023 Feb; 131(2):37-60. PubMed ID: 36394112
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccine: A comprehensive status report.
Kaur SP; Gupta V
Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
[TBL] [Abstract][Full Text] [Related]
14. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
Malik JA; Ahmed S; Mir A; Shinde M; Bender O; Alshammari F; Ansari M; Anwar S
J Infect Public Health; 2022 Feb; 15(2):228-240. PubMed ID: 35042059
[TBL] [Abstract][Full Text] [Related]
15. An overview on inactivated and live-attenuated SARS-CoV-2 vaccines.
Khoshnood S; Arshadi M; Akrami S; Koupaei M; Ghahramanpour H; Shariati A; Sadeghifard N; Heidary M
J Clin Lab Anal; 2022 May; 36(5):e24418. PubMed ID: 35421266
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the vaccine development for the prophylaxis of SARS Covid-19.
Kumar V; Kumar S; Sharma PC
Int Immunopharmacol; 2022 Oct; 111():109175. PubMed ID: 35994853
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus disease 2019 (COVID-19) vaccines: A concise review.
Samaranayake LP; Seneviratne CJ; Fakhruddin KS
Oral Dis; 2022 Nov; 28 Suppl 2():2326-2336. PubMed ID: 33991381
[TBL] [Abstract][Full Text] [Related]
18. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
19. Primed for global coronavirus pandemic: Emerging research and clinical outcome.
Ahamad S; Branch S; Harrelson S; Hussain MK; Saquib M; Khan S
Eur J Med Chem; 2021 Jan; 209():112862. PubMed ID: 33070079
[TBL] [Abstract][Full Text] [Related]
20. Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments.
Mahmud N; Anik MI; Hossain MK; Khan MI; Uddin S; Ashrafuzzaman M; Rahaman MM
ACS Appl Bio Mater; 2022 Jun; 5(6):2431-2460. PubMed ID: 35583460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
